Houston, TX, United States of America

Eric Boerwinkle

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eric Boerwinkle: Innovator in Cardiovascular Genetics

Introduction

Eric Boerwinkle is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of genetics, particularly in understanding cardiovascular diseases. With a total of 3 patents, his work has had a profound impact on medical research and diagnostics.

Latest Patents

One of Eric Boerwinkle's latest patents focuses on genetic polymorphisms associated with cardiovascular diseases, specifically coronary heart disease and hypertension. This invention provides compositions and methods based on these genetic polymorphisms. It includes nucleic acid molecules containing the polymorphisms, variant proteins encoded by these molecules, and reagents for detecting both the polymorphic nucleic acid molecules and the variant proteins. The methods outlined in this patent aim to utilize these nucleic acid molecules and proteins for detection and diagnostic purposes.

Career Highlights

Throughout his career, Eric Boerwinkle has worked with notable organizations such as Celera Corporation and the University of Texas System. His expertise in genetics and cardiovascular research has positioned him as a leader in his field.

Collaborations

Eric has collaborated with esteemed colleagues, including Dov Shiffman and James J Devlin, further enhancing the impact of his research and innovations.

Conclusion

Eric Boerwinkle's contributions to the field of cardiovascular genetics through his patents and collaborations highlight his role as a key innovator. His work continues to influence the understanding and detection of cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…